0001209191-14-046017.txt : 20140703 0001209191-14-046017.hdr.sgml : 20140703 20140703164233 ACCESSION NUMBER: 0001209191-14-046017 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20140701 FILED AS OF DATE: 20140703 DATE AS OF CHANGE: 20140703 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: VERTEX PHARMACEUTICALS INC / MA CENTRAL INDEX KEY: 0000875320 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 043039129 STATE OF INCORPORATION: MA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 50 NORTHERN AVENUE CITY: BOSTON STATE: MA ZIP: 02210 BUSINESS PHONE: 6173416393 MAIL ADDRESS: STREET 1: 50 NORTHERN AVENUE CITY: BOSTON STATE: MA ZIP: 02210 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Horton Kenneth L CENTRAL INDEX KEY: 0001552047 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19319 FILM NUMBER: 14961224 MAIL ADDRESS: STREET 1: VERTEX PHARMACEUTICALS INCORPORATED STREET 2: 130 WAVERLY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2014-07-01 0 0000875320 VERTEX PHARMACEUTICALS INC / MA VRTX 0001552047 Horton Kenneth L C/O VERTEX PHARMACEUTICALS INCORPORATED 50 NORTHERN AVENUE BOSTON MA 02210 0 1 0 0 EVP & Chief Legal Officer Common Stock 2014-07-01 4 M 0 28321 45.11 A 62597 D Common Stock 2014-07-01 4 S 0 2257 94.49 D 60340 D Common Stock 2014-07-01 4 S 0 27877 95.28 D 32463 D Common Stock 366 I 401(k) Stock Option (right to buy) 45.11 2014-07-01 4 M 0 28321 0.00 D 2013-05-05 2023-02-04 Common Stock 28321 62304 D Transaction made pursuant to Mr. Horton's company approved trading plan under Rule 10b5-1. Open market sales reported on this line occurred at a weighted average price of $94.49 (range $93.79 to $94.78). Mr. Horton undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. Open market sales reported on this line occurred at a weighted average price of $95.28 (range $94.79 to $95.66). Right to buy under 2006 Stock and Option Plan, vesting in 16 quarterly installments from 02/05/2013. Kenneth L. Horton 2014-07-03